Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0

Calabro G. E.

;Boccalini S.;Bechini A.;Panatto D.;Domnich A.;Lai P. L.;Amicizia D.;Rizzo C.;Pugliese A.;DI Pietro M. L.;Zanella B.;Parente F.;Trombetta C. S.;Saraceno G.;Sottile S.;Abreha F. M.;Giacchetta I.;Properzi S.;Santolini G.;D'Ambrosio F.;Maida A.;Scardigno A.;LA Gatta E.;Petrella L.;Bonanni P.;DE Waure C.

2022